<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04499105</url>
  </required_header>
  <id_info>
    <org_study_id>17-02-0143</org_study_id>
    <nct_id>NCT04499105</nct_id>
  </id_info>
  <brief_title>Effectiveness and Safety of Mesenchymal Stem Cell (MSC) Implantation on Degenerative Discus Disease Patients</brief_title>
  <acronym>MSC</acronym>
  <official_title>Effectiveness and Safety of Allogenic Mesenchymal Stem Cell (MSC) Implantation on Degenerative Discus Disease Patients (Clinical Trial)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ahmad Jabir Rahyussalim</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Indonesia University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the effectivity and safety of MSC implantation on Degenerative Disc&#xD;
      Disease Patients by assessing visual analog scale, ROM improvement and MRI examination.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The team plan to conduct research to look at the effectiveness and safety of mesenchymal stem&#xD;
      cell implantation therapy in intervertebral disc degeneration patients.&#xD;
&#xD;
      The use of allogenic mesenchymal stem cells from the umbilical cord was chosen because&#xD;
      patients with degeneration of the intervertebral disc are elderly (over 50 years old) so that&#xD;
      autologous mesenchymal stem cell administration is not possible in terms of taking the source&#xD;
      of cells (bone marrow) nor the quality of mesenchymal stem cells obtained.&#xD;
&#xD;
      This study will assess the improvement of clinical symptoms (VAS to assess pain scale, ASIA&#xD;
      and Frankel scale, as well as assessment of the widening of the lumbar region using the&#xD;
      Schober Test), changes in the structure of the intervertebral discs (through MRI examination&#xD;
      and grading the degree of intervertebral disc degeneration), conduction function spinal cord&#xD;
      nerve (somatosensory evoked potential / SSEP), myelography / EMG, and assessment of the&#xD;
      quality of life status of patients using the Oswestry Disability Index.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 24, 2017</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement of Low Back Pain</measure>
    <time_frame>6 months</time_frame>
    <description>Evaluates pain quality using Visual Analog Scale (VAS) from 0 - 10. Zero is no pain at all, one is the the least pain and ten is the most painful. The numbers are expected to be lower after MSC implantation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Tissue Improvement</measure>
    <time_frame>6 months</time_frame>
    <description>Tissue improvement confirmed by intervertebral disc MRI</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Degenerative Disc Disease</condition>
  <condition>Low Back Pain</condition>
  <condition>Disc Degeneration</condition>
  <arm_group>
    <arm_group_label>Mesenchymal Stem Cell</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mesenchymal Stem cell + Nacl 0.9%</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mesenchymal Stem Cell + NaCl 0,9% 2ml</intervention_name>
    <description>Patients enrolled in Cipto Mangunkusumo Hospital with degenerative disc disease with no promising result after conventional treatment.</description>
    <arm_group_label>Mesenchymal Stem Cell</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients enrolled in Cipto Mangunkusumo Hospital with degenerative disc disease with&#xD;
             no promising result after conventional treatment.&#xD;
&#xD;
          2. No history of metabolic, autoimun and genetic disease(s).&#xD;
&#xD;
          3. No active infection (HbsAg, HIV, CMV, Rubella).&#xD;
&#xD;
          4. Agree to participate the study by signing informed consent form.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients under 20 years old.&#xD;
&#xD;
          2. Declined to participate in the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ahmad Jabir Rahyussalim, PhD, SpOT(K)</last_name>
    <phone>+62811819466</phone>
    <email>rahyussalim71@ui.ac.id</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tri Kurniawati, S.Si</last_name>
    <phone>+628121134311</phone>
    <email>trie3k@ui.ac.id</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cipto Mangunkusumo Hospital</name>
      <address>
        <city>Jakarta Pusat</city>
        <state>DKI Jakarta</state>
        <zip>10430</zip>
        <country>Indonesia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ahmad Jabir Rahyussalim, MD,PhD,SpOT</last_name>
      <phone>+62811819466</phone>
      <email>rahyussalim71@ui.ac.id</email>
    </contact>
    <contact_backup>
      <last_name>Trie K Kurniawati, SSi</last_name>
      <phone>+628121134311</phone>
      <email>trie3k@ui.ac.id</email>
    </contact_backup>
    <investigator>
      <last_name>Ahmad Jabir Rahyussalim, MD,PhD,SpOT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Indonesia</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>July 30, 2020</study_first_submitted>
  <study_first_submitted_qc>July 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 5, 2020</study_first_posted>
  <last_update_submitted>August 4, 2020</last_update_submitted>
  <last_update_submitted_qc>August 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Indonesia University</investigator_affiliation>
    <investigator_full_name>Ahmad Jabir Rahyussalim</investigator_full_name>
    <investigator_title>Dr. dr. Rahyussalim SpOT(K)</investigator_title>
  </responsible_party>
  <keyword>DDD</keyword>
  <keyword>MSC</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intervertebral Disc Degeneration</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

